Wealth Quarterback’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$63K Buy
86,754
+86,369
+22,434% +$31.9M 0.04% 202
2021
Q2
$91K Buy
+385
New +$68.8K 0.06% 178
2020
Q2
Sell
-225
Closed -$6.74K 507
2020
Q1
$6.74K Buy
+225
New +$5.18K 0.01% 559

Other funds holding MRNA

Wealth Quarterback's MRNA Position: Q3 2021 in Review

Wealth Quarterback increased its Moderna (MRNA) stake by 22,434% in Q3 2021, buying an estimated $31.9M and bringing the position to 86,754 shares worth $63K. The position accounts for 0.04% of the portfolio, ranked #202.

Wealth Quarterback first reported a position in MRNA in Q1 2020 and has held it in 3 quarters since. The position peaked at $91K in Q2 2021. 1,140 funds tracked by Wall St. Rank hold MRNA as of Q3 2021.

  • Wealth Quarterback held 86,754 shares of Moderna worth $63K as of Q3 2021.
  • Wealth Quarterback bought 86,369 Moderna shares in Q3 2021, an estimated $31.9M.
  • Moderna made up 0.04% of Wealth Quarterback's portfolio in Q3 2021, its #202 holding.
  • Wealth Quarterback first reported a position in Moderna in Q1 2020 and has held it in 3 quarters since.
  • Wealth Quarterback's Moderna position peaked at $91K in Q2 2021.
  • 1,140 funds tracked by Wall St. Rank held Moderna as of Q3 2021.

Based on Wealth Quarterback's 13F filing for Q3 2021, filed 17 Nov 2021.